Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > People > Dr Charles Bailey

Dr Charles Bailey

Head, Centre for Rare Diseases & Gene Therapy

Laboratories

  • Bailey

Phone number Phone Number 61 2 9565 6171

Email Email c.bailey@centenary.org.au

Dr Chuck (Charles) Bailey, is the head of the Cancer and Gene Regulation Laboratory at the Centenary Institute. He trained as a molecular and cellular biologist (PhD, CRC for Biopharmaceutical Research, UNSW) and has 20 years’ experience in studying molecular mechanisms of genetic disease and cancer. In 2001, he joined the Gene and Stem Cell Therapy Program headed by Professor John Rasko at the Centenary Institute studying the molecular genetics of human amino acid transporter disorders. His work lead to the discovery of the genetic causes of 3 of the 5 principal inherited amino acid transport disorders in humans, published in Nature Genetics and The Journal of Clinical Investigation (x2).

He was appointed as a Senior Research Officer in 2007 and where he began studying the role of transcription factors in cancer causation. By understanding fundamental gene regulatory mechanisms in normal biology, he is applying this knowledge to elucidating aberrant transcription factor function in cancer. With a particular focus on the chromatin organising protein CTCF, and its paralogue BORIS, he has been examining gene regulatory circuitry and protein interaction networks that are essential in cancer.

Themes

  • Rare Diseases & Gene Therapy

Topics

  • Chronic diseases ,

Publications

all publications

For access to all Publications via Pub Med.

News

  • Funding boost for pioneering gene therapy and liver disease research

    Centenary Institute researchers have achieved success in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants, securing funding for innovative work in rare genetic diseases and liver disease.
    Date 06 Jan 2026
  • Centenary Institute delivers Tour de Cure milestone

    A recent discovery from the Centenary Institute has been recognised as the 200th scientific breakthrough funded by cancer charity Tour de Cure since it began supporting research in 2007.
    Date 05 Aug 2025
  • New route into cells could make gene therapies safer

    Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.
    Date 15 Jul 2025
  • Centenary researchers awarded TIA Pipeline Accelerator Grants

    Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.
    Date 07 Jul 2025
  • Radio 2GB interviews Dr Chuck Bailey

    Dr Chuck Bailey, Head of the Centre for Rare Diseases & Gene Therapy at the Centenary Institute, was recently interviewed by 2GB host Bill Woods.
    Date 23 Dec 2024
View all

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram